Blues TEC Assessment Endorses CRT For Mild Heart Failure

Using cardiac resynchronization therapy to treat patients suffering from mild heart failure is supported by existing clinical evidence. That is not the case, however, for asymptomatic patients, according to a new assessment issued by Blue Cross Blue Shield’s Technology Evaluation Center.

More from Archive

More from Medtech Insight